Mogamulizumab + Low-Dose Total Skin Electron Beam Tx in Mycosis Fungoides & Sézary Syndrome

NCT04256018 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Sezary Syndrome
Mycosis Fungoides

Interventions

DRUG: Mogamulizumab
RADIATION: LD TSEBT

Sponsor

Stanford University